🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07348731
Recruiting Not applicable

Non-Pharmacological Methods in Heel Lance

NCT07348731 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-02-25
Last updated
2026-06-02

Condition(s) studied

Heel Lance Procedures

Investigational drug(s) / intervention(s)

Foot bath

Foot bath: The infant's foot designated for blood sampling will be immersed up to the mid-calf level in water adjusted to 37-38°C, using a thermometer for confirmation, and kept there for 5 minutes. The heel lance procedure will then be performed by the nurse working in the clinic, following the standard clinical routine. The video recording will be stopped once bleeding has ceased at the end of the procedure. The video recordings obtained before, during, and after the procedure will be reviewed, and the infant's pain scores will be assessed by two independent experts.

Study summary

This randomized controlled study was designed to compare the effects of Warm Foot Bath, ShotBlocker®, and Buzzy®-applied prior to heel lance-on the vital signs of newborns. Heel lance is one of the most frequently performed invasive procedures during the neonatal period, and the pain and stress experienced during the procedure may lead to alterations in vital parameters such as heart rate, respiratory rate, and oxygen saturation. Therefore, identifying non-pharmacological, safe, and feasible pain management methods is essential for enhancing the quality of nursing care.

Data will be collected at three time points: before, during, and after the procedure, and changes in heart rate, respiratory rate, and SpO₂ will be recorded. With parental consent, the procedure will be video-recorded before, during, and after heel lance; the recordings will be anonymized and shared with experts for pain assessment. Additionally, the infant's crying duration and time to bleeding cessation will also be evaluated.

Eligibility

Sex
ALL
Min age
4 Days
Max age
1 Month
Healthy volunteers
Accepted
Inclusion Criteria: * Newborns with a gestational age of ≥37 weeks * Newborns in the neonatal period (0-28 days) * Stable vital signs * Obtained informed consent from the parents * No use of analgesics or sedatives within the 24 hours before the procedure * Absence of any respiratory problems * First-time heel lance procedure * No condition that would interfere with pain assessment Exclusion Criteria: * Preterm or low birth weight infants (\< 2500 g) * Infants with congenital anomalies or requiring respiratory support * Infants receiving sedative or analgesic treatment

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Atlas University Istanbul Kağıthane Recruiting

More Atlas University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07348731 on ClinicalTrials.gov ↗ ← All trials in Turkey